Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (AMLSG)

  • F Theis
  • A Corbacioglu
  • V I Gaidzik
  • P Paschka
  • D Weber
  • L Bullinger
  • M Heuser
  • A Ganser
  • F Thol
  • B Schlegelberger
  • G Göhring
  • C-H Köhne
  • U Germing
  • P Brossart
  • H-A Horst
  • D Haase
  • K Götze
  • M Ringhoffer
  • W Fiedler
  • D Nachbaur
  • T Kindler
  • G Held
  • M Lübbert
  • M Wattad
  • H R Salih
  • J Krauter
  • R F Schlenk
  • K Döhner

Related Research units

Abstract

Leukemia accepted article preview online, 04 July 2016. doi:10.1038/leu.2016.185.

Bibliographical data

Original languageEnglish
ISSN0887-6924
DOIs
Publication statusPublished - 11.2016

Comment Deanary

Letters to the Editor

PubMed 27375010